Mitragynine

(16E,20b)-16,17-Didehydro-9,17-dimethoxycorynan-16-carboxylic Acid Methyl Ester

(16E,20β)-9,17-Diméthoxycoryn-16-én-16-carboxylate de méthyle

(−)-Mitragynine

4098-40-2

6202-22-8

9-Methoxycorynantheidine

Corynan-16-carboxylic acid, 16,17-didehydro-9,17-dimethoxy-, methyl ester, (16E,20β)-

EP479K822J

Indolo[2,3-a]quinolizine-2-acetic acid, 3-ethyl-1,2,3,4,6,7,12,12b-octahydro-8-methoxy-alpha-(methoxymethylene)-, methyl ester, (alphaE,2S,3S,12bS)-

Methyl (16E,20β)-9,17-dimethoxycoryn-16-en-16-carboxylate

methyl (16E,20β)-9-methoxy-16-(methoxymethylidene)corynan-17-oate

Methyl-(16E,20β)-9,17-dimethoxycoryn-16-en-16-carboxylat

MFCD09838906

Mitragynine

[Wiki]

(a-E,2S,3S,12bS)-3-Ethyl-1,2,3,4,6,7,12,12b-octahydro-8-methoxy-a-(methoxymethylene)-indolo[2,3-a]quinolizine-2-acetic acid methyl ester

(E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[3,2-h]quinolizin-2-yl]-3-methoxyprop-2-enoic acid methyl ester

(E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydropyrido[2,1-a]$b-carbolin-2-yl]-3-methoxy-acrylic acid methyl ester

(E)-Methyl 2-((2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate

(E)-Methyl2-((2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate

(E)methyl 2-((2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate

16,17-Didehydro-9,17-dimethoxy-17,18-seco-20-α-yohimban-16-carboxylic acid methyl ester

2-(3-Ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydro-indolo[2,3-a]quinolizin-2-yl)-3-methoxy-acrylic acid methyl ester

5-hydroxytryptamine receptor 1A

5-hydroxytryptamine receptor 2A

5-hydroxytryptamine receptor 2B

5-hydroxytryptamine receptor 2C

5-hydroxytryptamine receptor 7

5HT1A_HUMAN

5HT2A_HUMAN

5HT2B_HUMAN

5HT2C_HUMAN

5HT7R_HUMAN

9-Methoxy-corynantheidine

CP2D6_HUMAN

Cytochrome P450 2D6

METHYL (2E)-2-[(2S,3S,12BS)-3-ETHYL-8-METHOXY-1H,2H,3H,4H,6H,7H,12H,12BH-INDOLO[2,3-A]QUINOLIZIN-2-YL]-3-METHOXYPROP-2-ENOATE

methyl (2E)-2-[(2S,4S,5S)-5-ethyl-12-methoxy-7,17-diazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(10),11(16),12,14-tetraen-4-yl]-3-methoxyprop-2-enoate

methyl (2E)-2-[(2S,4S,5S)-5-ethyl-12-methoxy-7,17-diazatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),11,13,15-tetraen-4-yl]-3-methoxyprop-2-enoate

methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate

methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[3,2-h]quinolizin-2-yl]-3-methoxy-prop-2-enoate

methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[3,2-h]quinolizin-2-yl]-3-methoxyprop-2-enoate

MFCD00189432

MITRAGYNINE PICRATE

OPRD_HUMAN

OPRD_MOUSE

OPRK_CAVPO

OPRK_HUMAN

OPRK_MOUSE

OPRM_CAVPO

OPRM_HUMAN

OPRM_MOUSE

SK&F 12711

Δ-type opioid receptor

κ-type opioid receptor

μ-type opioid receptor